South Africa has launched lenacapavir, a new injectable form of pre-exposure prophylaxis, or PrEP. The injection provides six months of protection against HIV infection. It is given twice a year. Health experts say the Lenacapavir PrEP Rollout could be a major step forward for HIV prevention. It offers an alternative to oral PrEP, which requires people to take tablets regularly.…
Tag: Key Populations
-
HIV Funding in South Africa Faces Serious Cuts
South Africa has less than eight years before one of its most important external funding streams for HIV and TB programmes ends. Allocation letters sent in March confirm that the Global Fund to Fight Aids, Tuberculosis and Malaria plans its final grant to South Africa in Grant Cycle 9. This cycle will run from April 2031 to March 2034. At…
-
HIV/AIDS Programme Remains Strong Amid Funding Cuts
Health Minister Aaron Motsoaledi has provided reassurances on the future of South Africa’s HIV/Aids programme following the withdrawal of PEPFAR funding. He detailed the government’s mitigation efforts and engagements with potential donors.1 HIV/AIDS Programme ‘Not at Risk of Collapsing’ Health Minister Aaron Motsoaledi has moved to quell fears surrounding the future of South Africa’s HIV/Aids response. He firmly stated the…